Ocular Therapeutix, Inc. (NASDAQ: OCUL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT OCULAR THERAPEUTIX, INC.

Ocular Therapeutix, Inc. (NASDAQ: OCUL)
Listen to this Section


$8.81
+0.4570 ( +5.47% ) 946.4K

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Market Data


Open $8.81
Previous Close $8.35
Volume 946.4K
Market Cap $1.83B
Day Range $8.36 - $8.95
52 Week Range $6.23 - $16.44
Shares Outstanding 218.96M
Change % +5.47%
Net Change ▲ 0.4570
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2014
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -68,939.00

Date Type Amount Purchased Purchaser
2025-05-12 Buy 10000.00 LINDSTROM RICHARD L MD
2024-07-26 Sale -12000.00 Graves Adrienne L
2024-07-26 Sale -12000.00 Warden Charles M
2024-07-26 Sale -12000.00 Williams Leslie J.
2024-07-26 Sale -12000.00 RAINES MERILEE
2024-07-26 Sale -12000.00 Hong Seung Suh
2024-07-26 Sale -18939.00 LINDSTROM RICHARD L MD

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 07, 2025
8-k 8K-related 14 Nov 04, 2025
10-q Quarterly Reports 76 Nov 04, 2025
4 Insider transactions 2 Oct 10, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
8-k 8K-related 12 Sep 30, 2025
8-k 8K-related 19 Sep 30, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 2 Sep 04, 2025

Latest News


× Before browsing our site, please accept our cookies policy